Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport

Bioconjugate Chemistry

Volumn 19, Issue 10, 2008, Pages 2023-2029

  Sahay, Gaurav ^a   Batrakova, Elena V ^a   Kabanov, Alexander V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BLOCK COPOLYMERS; CELL MEMBRANES; DISEASES; DRUG DELIVERY; DRUG DOSAGE; ETHYLENE; GENE EXPRESSION; MAMMALS; MICELLES; POLYETHYLENE OXIDES;

CAVEOLAE; CELL-BE; CELL/B.E; CELL/BE; CHOLERA TOXIN B; CLATHRINS; CRITICAL MICELLER CONCENTRATIONS; PLURONICS; POLY(PROPYLENE OXIDE); UNIMERS;

MOLECULAR BIOLOGY;

CAVEOLIN 1; CHOLERA TOXIN B SUBUNIT; CLATHRIN; COPOLYMER; MACROGOL; POLOXAMER; POLOXAMER P85; POLY(PROPYLENE OXIDE); POLYMER; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CAVEOLA; CRITICAL MICELLE CONCENTRATION; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; INTERNALIZATION; MICELLE; NONHUMAN;

MAMMALIA;

EID: 55249093646     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc8002315     Document Type: Article

References (57)

1. Kabanov, A. V., and Alakhov, V. Y. (2002) Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit. Rev. Ther. Drug Carrier Syst. 19, 1-72.
2. Kabanov, A. V., Batrakova, E. V., and Alakhov, V. Y. (2002) Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Controlled Release 82, 189-212.
3. Batrakova, E. V., Li, S., Miller, D. W., and Kabanov, A. V. (1999) Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm. Res. 16, 1366-72.
4. Kabanov, A. V., Slepnev, V. I., Kuznetsova, L. E., Batrakova, E. V., Alakhov, V., Melik-Nubarov, N. S., Sveshnikov, P. G., and Kabanov, V. A. (1992) Pluronic micelles as a tool for low-molecular compound vector delivery into a cell: effect of Staphylococcus aureus enterotoxin B on cell loading with micelle incorporated fluorescent dye. Biochem. Int. 26, 1035-42.
5. Chekhonin, V. P., Kabanov, A. V., Zhirkov, Y. A., and Morozov, G. V. (1991) Fatty acid acylated Fab-fragments of antibodies to neurospecific proteins as carriers for neuroleptic targeted delivery in brain. FEBS Lett. 287, 149-52.
6. Alakhov, V., Klinski, E., Lemieux, P., Pietrzynski, G., and Kabanov, A. (2001) Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Opin. Biol. Ther. 1, 583-602.
7. Batrakova, E. V., Li, S., Vinogradov, S. V., Alakhov, V. Y., Miller, D. W., and Kabanov, A. V. (2001) Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. J. Pharmacol. Exp. Ther. 299, 483-93.
8. Kabanov, A. V., Lemieux, P., Vinogradov, S., and Alakhov, V. (2002) Pluronic block copolymers: novel functional molecules for gene therapy. Adv. Drug Delivery Rev. 54, 223-33.
9. Batrakova, E. V., Li, S., Alakhov, V. Y., Miller, D. W., and Kabanov, A. V. (2003) Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J. Pharmacol. Exp. Ther. 304, 845-54.
10. Batrakova, E. V., Li, S., Elmquist, W. F., Miller, D. W., Alakhov, V. Y., and Kabanov, A. V. (2001) Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br. J. Cancer 85, 1987-97.
11. Batrakova, E. V., Li, S., Li, Y., Alakhov, V. Y., and Kabanov, A. V. (2004) Effect of pluronic P85 on ATPase activity of drug efflux transporters. Pharm. Res. 21, 2226-33.
12. Yang, Z., Zhu, J., Sriadibhatla, S., Gebhart, C., Alakhov, V., and Kabanov, A. (2005) Promoter- and strain-selective enhancement of gene expression in a mouse skeletal muscle by a polymer excipient Pluronic P85. J. Controlled Release 108, 496-512.
13. Kabanov, A. V. (2006) Polymer genomics: an insight into pharmacology and toxicology of nanomedicines. Adv. Drug Delivery Rev. 58, 1597-621.
14. Sriadibhatla, S., Yang, Z., Gebhart, C., Alakhov, V. Y., and Kabanov, A. (2006) Transcriptional activation of gene expression by pluronic block copolymers in stably and transiently transfected cells. Mol. Ther. 13, 804-13.
15. Batrakova, E. V., Vinogradov, S. V., Robinson, S. M., Niehoff, M. L., Banks, W. A., and Kabanov, A. V. (2005) Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. Bioconjugate Chem. 16, 793-802.
16. Conner, S. D., and Schmid, S. L. (2003) Regulated portals of entry into the cell. Nature 422, 37-44.
17. Abbott, N. J., Ronnback, L., and Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53.
18. Carver, L. A., and Schnitzer, J. E. (2003) Caveolae: mining little caves for new cancer targets. Nat. Rev. Cancer 3, 571-81.
19. Romberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., and Anderson, R. G. W. (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68, 673-682.
20. Nichols, B. (2003) Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 116, 4707-4714.
21. Nabi, I. R., and Le, P. U. (2003) Caveolae/raft-dependent endocytosis. J. Cell Biol. 161, 673-677.
22. Mayor, S., and Pagano, R. E. (2007) Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8, 603-612.
23. Kabanov, A. V., Levashov, A. V., and Alakhov, V. (1989) Lipid modification of proteins and their membrane transport. Protein Eng. 3, 39-42.
24. Kabanov, A. V., Levashov, A. V., Alakhov, V., Martinek, K., and Severin, E. S. (1990) Fatty acylation of proteins for translocation across cell membranes. Biomed. Sci. 1, 33-6.
25. Barakat, S., Demeule, M., Pilorget, A., Regina, A., Gingras, D., Baggetto, L. G., and Beliveau, R. (2007) Modulation of p-glycoprotein function by caveolin-1 phosphorylation. J. Neurochem. 101, 1-8.
26. Batrakova, E. V., Miller, D. W., Li, S., Alakhov, V. Y., Kabanov, A. V., and Elmquist, W. F. (2001) Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J. Pharmacol. Exp. Ther. 296, 551-7.
27. Herzlinger, D. A., Easton, T. G., and Ojakian, G. K. (1982) The MDCK epithelial cell line expresses a cell surface antigen of the kidney distal tubule. J. Cell Biol. 93, 269-277.
28. Hailstones, D., Sleer, L. S., Parton, R. G., and Stanley, K. K. (1998) Regulation of caveolin and caveolae by cholesterol in MDCK cells. J. Lipid Res. 39, 369-379.
29. Self, T. J., Oakley, S. M., and Hill, S. J. (2005) Clathrin-independent internalization of the human histamine H1-receptor in CHO-K1 cells. Br. J. Pharmacol. 146, 612-624.
30. Heuser, J. E., and Anderson, R. G. (1989) Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol. 108, 389-400.
31. Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, M., Tanaka, S., Ueda, K., Simpson, J. C., Jones, A. T., Sugiura, Y., and Futaki, S. (2004) Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10, 1011-1022.
32. Jones, A. T. (2007) Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J. Cell. Mol. Med. 11, 670-684.
33. Kabanov, A. V., Nazarova, I. R., Astafieva, I. V., Batrakova, E. V., Alakhov, V. Y., Yaroslavov, A. A., and Kabanov, V. A. (1995) Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions. Macromolecules 2303-2314.
34. Ivanov, A. I. (2008) Pharmacological inhibition of endocytic pathways: Is it specific enough to be useful? Methods Mol. Biol. 440, 15-33.
35. Rodal, S. K., Skretting, G., Garred, O., Vilhardt, F., van Deurs, B., and Sandvig, K. (1999) Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 10, 961-74.
36. Subtil, A., Gaidarov, I., Kobylarz, K., Lampson, M. A., Keen, J. H., and McGraw, T. E. (1999) Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc. Natl. Acad. Sci. U.S.A. 96, 6775-80.
37. Duncan, R. (2006) Polymer conjugates as anticancer nano-medicines. Nat. Rev. Cancer 6, 688-701.
38. Torchilin, V. P. (2000) Polymeric contrast agents for medical imaging. Curr. Pharm. Biotechnol. 1, 183-215.
39. Kopecek, J. (2002) Polymer chemistry: swell gels. Nature 417, 388-9-391.
40. Batrakova, E. V., Han, H. Y., Miller, D. W., and Kabanov, A. V. (1998) Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm. Res. 15, 1525-32.
41. Lemieux, P., Guerin, N., Paradis, G., Proulx, R., Chistyakova, L., Kabanov, A., and Alakhov, V. (2000) A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther. 7, 986-91.
42. Oh, K. T., Bronich, T. K., and Kabanov, A. V. (2004) Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J. Controlled Release 94, 411-22.
43. Kabanov, A. V., Batrakova, E. V., and Miller, D. W. (2003) Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv. Drug Delivery Rev. 55, 151-64.
44. Batrakova, E. V., Li, S., Alakhov, V. Y., Elmquist, W. F., Miller, D. W., and Kabanov, A. V. (2003) Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharm. Res. 20, 1581-90.
45. Minko, T., Batrakova, E. V., Li, S., Li, Y., Pakunlu, R. I., Alakhov, V. Y., and Kabanov, A. V. (2005) Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. J. Controlled Release 105, 269-78.
46. Simons, K., and Toomre, D. (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol 1, 31-39.
47. Kabanov, A. V., and Kabanov, V. A. (1998) Interpolyelectrolyte and block ionomer complexes for gene delivery: physicochemical aspects. Adv. Drug Delivery Rev. 30, 49-60.
48. Bronich, T. K., Nguyen, H. K., Eisenberg, A., and Kabanov, A. V. (2000) Recognition of DNA topology in reactions between plasmid DNA and cationic copolymers. J. Am. Chem. Soc. 122, 8339-8343.
49. Miller, D. W., Batrakova, E. V., Waltner, T. O., Alakhov, V., and Kabanov, A. V. (1997) Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Bioconjugate Chem. 8, 649-57.
50. Batrakova, E. V., Han, H. Y., Alakhov, V., Miller, D. W., and Kabanov, A. V. (1998) Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res. 15, 850-5.
51. Damke, H., Baba, T., Warnock, D. E., and Schmid, S. L. (1994) Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell Biol. 127, 915-934.
52. Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., and Hubbell, J. A. (2007) Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 25, 1159-1164.
53. Moghimi, S. M., Hunter, A. C., Dadswell, C. M., Savay, S., Alving, C. R., and Szebeni, J. (2004) Causative factors behind poloxamer 188 (Pluronic F68, Flocor(TM))-induced complement activation in human sera: A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels. Biochim. Biophys. Acta 1689, 103-113.
54. Klink, D., Yu, Q.-C., Glick, M. C., and Scanlin, T. (2003) Lactosylated poly-L-lysine targets a potential lactose receptor in cystic fibrosis and non-cystic fibrosis airway epithelial cells. Mol Ther 7, 73-80.
55. Jodoin, J., Demeule, M., Fenart, L., Cecchelli, R. o., Farmer, S., Linton, K. J., Higgins, C. F., and Béliveau, R. R. (2003) P-glycoprotein in blood brain barrier endothelial cells: interaction and oligomerization with caveolins. J. Neurochem. 87, 1010.
56. Palmer, W. K., Emeson, E. E., and Johnston, T. P. (1998) Poloxamer 407-induced atherogenesis in the C57BL/6 mouse. Atherosclerosis 136, 115-123.
57. Anderson, R. G. W. (1998) The caveolae membrane system. Annu. Rev. Biochem. 67, 199-225.